Benzinga's Top #PreMarket Gainers
August 20, 2014 at 08:10 AM EDT
Amicus Therapeutics (NASDAQ: FOLD) jumped 24.95% to $5.71 in pre-market trading after the company reported positive Phase 3 data From ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.